Clinical Trial Update: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ibandronate (Bonviva) and alendronate on renal function in postmenopausal osteoporosis patients at high risk for kidney disease; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)
• alendronate (alendronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post-Menopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2011-06-17